Skip to main content

Publication, Part of

Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 by CCG in England, 2019

Current Chapter

Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 by CCG in England, 2019


Summary

This publication presents the 1- and 3- year unadjusted and case-mix adjusted ‘percentage of all cancers diagnosed at stages 1 and 2’ indicator nationally and at Clinical Commissioning Group (CCG) level. The most recently available results are for cancers diagnosed in 2019, with data available from 2013. The unadjusted percentage of cancers diagnosed at each stage is also provided by cancer site/group and deprivation quintile. It also presents the 1-year rolling unadjusted ‘percentage of all cancers diagnosed at stages 1 and 2’ indicator (known as the ‘75% ambition’ indicator) nationally and at Cancer Alliance level, for 2013 to 2019.


Key Facts

The unadjusted percentage of cancers diagnosed at stages 1 and 2 remains stable

55% of cancers with a valid stage were diagnosed at stages 1 and 2 in 2019, this is comparable to 2018.

Part of the variation in the percentage of cancers diagnosed at stages 1 and 2 between CCGs is associated with population characteristics

Case-mix adjusted percentages across the 106 CCGs range from 50.6% to 58.5% in 2017 to 2019, which is smaller than the unadjusted range (49.1% to 59.7%).

The unadjusted percentage of cancers diagnosed at stages 1 and 2 is lower in areas with higher deprivation

The unadjusted percentage of cancers diagnosed at stages 1 and 2 in the 20% most deprived areas of England is 7.7 percentage points lower than for those in the 20% least deprived areas

The unadjusted percentage of cancers diagnosed at stages 1 and 2 varied by cancer site

This ranged from 19.7% (Oesophagus including cardia and gastroesophageal junction) to 90.2% (testis)

On 1 October 2021, responsibility for the National Disease Registration Service (NDRS) transferred from Public Health England (PHE) to NHS Digital. NHS Digital is the data controller for this data. The National Cancer Registration and Analysis Service (NCRAS) as part of the NDRS is still responsible for collecting data on patients with cancer in England and continues to produce the cancer statistics publications.

Previous releases of these statistics can be found at the link below.

Acknowledgements

This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data are collated, maintained and quality assured by the National Disease Registration Service, which is part of NHS Digital.

We would like to thank the methodology development group for their work in developing the initial ‘case-mix adjusted percentage of cancers diagnosed at stages 1 and 2’ indicator: Dr Gary Abel; Dr Matthew Barclay; Professor Yoryos Lyratzopoulos; Dr Brian Rous; Rafael Goriwoda; Lucy Ironmonger; Dr Harriet Fisher; Dr Katherine Henson; Dr Sean McPhail.




Last edited: 15 December 2021 2:33 pm